QA: Immunogen Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000855654_2015_Immunogen_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0000855654, Immunogen Inc

  xvar xval
0 AssetsCurrent 150,756,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 14,349,000
3 remainder_Assets 213,000
4 LiabilitiesCurrent 21,254,000
5 LiabilitiesNoncurrent 3,717,000
6 remainder_Liabilities 64,648,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,639,229
9 ResearchAndDevelopmentExpense 111,554,646
10 remainder_Expenses 0
11 remainder_Revenues 81,178,250
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 174,873
  yvar yval
0 Assets 165,318,000
1 Liabilities 89,619,000
2 Expenses 137,193,875
3 Revenues 81,178,250
4 StockholdersEquity 75,699,000
5 NetIncome -56,015,625
6 ComprehensiveNetIncome -55,928,188
7 BaseVar 236,741,999
8 EconomicCapitalRatiobeforeLimitedLiability 0.856
9 EconomicCapitalRatio 2.19

Edgar->Model Mapping

Feature Distribution

Change over Time